(Society of Interventional Radiology) Y-90: Are You Ready? -- an intensive course examining radiation biology, dosimetry, radiation safety, embolotherapy and clinical office management in the use of yttrium-90 in the treatment of cancer -- is being offered by the Society of Interventional Radiology Feb. 9-12 in Scottsdale, Ariz. The course ...

Tocagen Inc. has announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma. Almost all mice receiving the top dose of Toca 511 followed by 5-FC were still alive at 180 days, ...

Jim Black is fighting the meanest, most aggressive, most common kind of brain tumor in the United States: recurrent glioblastoma multiforme (GBM). In the United States, each year, approximately 10,000 patients are affected by GBM. Now, a novel investigational device - available only at clinical trial sites - is offering ...

When the body’s own cells turn into ticking time bombs, as in cases of viral infection or cancerous transformation, a mechanism known as ‘cross-presentation’ enables the immune system’s dendritic cells (DCs) to sound the alarm. 

(Canale Communications) Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma. Almost all mice receiving the top dose of Toca 511 followed by 5-FC were still alive at ...

(University of California - San Diego) In the United States, each year, approximately 10,000 patients are affected by recurrant glioblastoma multiforme. Now, a novel investigational device - available only at clinical trial sites - is offering new hope to these patients.

The week before and two weeks after surgery are a critical period for the long-term survival rate of cancer patients. Physiological and psychological stresses caused by the surgery itself can inhibit the body's immune responses, heightening vulnerability to tumor progression and spreading.

Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors. The unique test could preclude the need for surgery in patients whose tumors are located in areas of the brain too dangerous to biopsy. ...

(American Friends of Tel Aviv University) Prof. Shamgar Ben-Eliyahu of Tel Aviv University is combining two medications originally used to treat excessive stress and inflammatory responses, the culmination of 15 years of research on the connection between the body's stress responses, immune functions, and tumor metastasis. If these trials are ...

An assay which measures the activity of 14 genes in lung cancer tumors can accurately predict who will respond well to surgery and who will probably die within five years, researchers from the University of California, San Francisco, reported in The Lancet. 80% of lung cancer patients have NSCLC (non-small-cell ...

DALLAS Jan. 26, 2012 Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors. The unique test could preclude the need for surgery in patients whose tumors are located in areas of ...

Researchers at Queen's University in Kingston, Canada have identified a possible cause for the loss of a tumour suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer.